Tower Research Capital LLC (Trc) Novo Cure LTD Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Novo Cure LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,034 shares of NVCR stock, worth $44,849. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,034
Previous 8,703
76.63%
Holding current value
$44,849
Previous $136,000
55.88%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding NVCR
# of Institutions
288Shares Held
75.6MCall Options Held
1.77MPut Options Held
538K-
Black Rock Inc. New York, NY12.1MShares$268 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$260 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA8.87MShares$196 Million0.05% of portfolio
-
Capital World Investors Los Angeles, CA4.82MShares$106 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.74MShares$60.4 Million5.68% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.31B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...